Simplex Trading
DNA icon

Simplex Trading’s Ginkgo Bioworks DNA Stock Holding History

Simplex Trading’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.08M Buy
84,325
+66,330
+369% +$540K ﹤0.01% 2641
2026
Q2 		$178K Buy
17,995
+10,521
+141% +$88K ﹤0.01% 4859
2026
Q1 		$45.8K Buy
+7,474
New +$62.2K ﹤0.01% 5969
2025
Q4 		– Sell
-23,533
Closed -$343K – 8878
2025
Q3 		$343K Buy
+23,533
New +$282K ﹤0.01% 4294
2025
Q2 		– Sell
-37,775
Closed -$293K – 8868
2025
Q1 		$215K Sell
37,775
-9,328
-20% -$95K ﹤0.01% 4247
2024
Q4 		$462K Buy
+47,103
New +$404K ﹤0.01% 3623
2024
Q3 		– Sell
-5,841
Closed -$58.5K – 8701
2024
Q2 		$78K Sell
5,841
-3,710
-39% -$111K ﹤0.01% 5627
2024
Q1 		$443K Buy
9,551
+2,628
+38% +$136K ﹤0.01% 3967
2023
Q4 		$468K Buy
6,923
+3,726
+117% +$228K ﹤0.01% 3773
2023
Q3 		$231K Sell
3,197
-3,338
-51% -$267K ﹤0.01% 4194
2023
Q2 		$486K Buy
6,535
+6,442
+6,927% +$381K ﹤0.01% 3349
2023
Q1 		$4K Buy
93
+84
+933% +$5.32K ﹤0.01% 8157
2022
Q4 		$0 Buy
9
+3
+50% +$276 ﹤0.01% 9416
2022
Q3 		$0 Sell
6
-1,230
-100% -$147K ﹤0.01% 10087
2022
Q2 		$117K Sell
1,236
-4,909
-80% -$599K ﹤0.01% 5356
2022
Q1 		$990K Buy
+6,145
New +$1.2M ﹤0.01% 2938

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
J.M. Forbes & Co
J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.3B AUM 33.78% 1-Year Est. Return

Simplex Trading's DNA Position: Q3 2026 in Review

Simplex Trading increased its Ginkgo Bioworks (DNA) stake by 369% in Q3 2026, buying an estimated $540K and bringing the position to 84,325 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2641.

Simplex Trading first reported a position in DNA in Q1 2022 and has held it in 16 quarters since. 64 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Simplex Trading held 84,325 shares of Ginkgo Bioworks worth $1.08M as of Q3 2026.
  • Simplex Trading bought 66,330 Ginkgo Bioworks shares in Q3 2026, an estimated $540K.
  • Ginkgo Bioworks made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #2641 holding.
  • Simplex Trading first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 16 quarters since.
  • 64 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.